Alexander Kretschmer1, Victor Nitti2. 1. Ludwig-Maximilians Universität, Urologische Klinik und Poliklinik, Campus Großhadern, Munich, Germany. Electronic address: Alexander.kretschmer@med.uni-muenchen.de. 2. Department of Urology, NYU Langone Medical Center, New York, NY, USA.
Abstract
CONTEXT: Radical prostatectomy is the most common reason for male stress urinary incontinence. There is still insecurity about its therapeutic management. OBJECTIVE: To evaluate current evidence regarding therapy of postprostatectomy incontinence (PPI). EVIDENCE ACQUISITION: In October 2017, a nonsystematic review of the literature published within the last 2 yr was performed using the PubMed/Medline database. In total, 58 articles were included in the current analysis. EVIDENCE SYNTHESIS: Regarding invasive management of moderate-to-severe PPI, artificial urinary sphincter (AUS) is still the treatment of choice. Recent studies focused on efficacy, but also a plethora of potential predictive features for treatment success has been investigated. Owing to inconsistent results, there still is no consensus about valid risk factors of AUS treatment success to date. There are increasing efficacy data about the use of adjustable slings, and long-term follow-up results are now available for the AdVanceXP male sling. Evidence addressing the use of the quadratic Virtue male sling needs further evaluation. To date, there is no randomized controlled trial investigating the outcome of one specific surgical treatment or comparing the outcome of different surgical treatment options. Limitations include the nonsystematic approach. CONCLUSIONS: Level of evidence addressing the surgical management of PPI is increasing but still unsatisfying. PATIENT SUMMARY: In this review article, we look at current research regarding surgical management of stress urinary incontinence following radical prostatectomy. Many studies focus on how to predict treatment failure and outcomes after artificial urinary sphincter implantation. In addition, more information on the long-term results after male sling implantation is now available.
CONTEXT: Radical prostatectomy is the most common reason for male stress urinary incontinence. There is still insecurity about its therapeutic management. OBJECTIVE: To evaluate current evidence regarding therapy of postprostatectomy incontinence (PPI). EVIDENCE ACQUISITION: In October 2017, a nonsystematic review of the literature published within the last 2 yr was performed using the PubMed/Medline database. In total, 58 articles were included in the current analysis. EVIDENCE SYNTHESIS: Regarding invasive management of moderate-to-severe PPI, artificial urinary sphincter (AUS) is still the treatment of choice. Recent studies focused on efficacy, but also a plethora of potential predictive features for treatment success has been investigated. Owing to inconsistent results, there still is no consensus about valid risk factors of AUS treatment success to date. There are increasing efficacy data about the use of adjustable slings, and long-term follow-up results are now available for the AdVanceXP male sling. Evidence addressing the use of the quadratic Virtue male sling needs further evaluation. To date, there is no randomized controlled trial investigating the outcome of one specific surgical treatment or comparing the outcome of different surgical treatment options. Limitations include the nonsystematic approach. CONCLUSIONS: Level of evidence addressing the surgical management of PPI is increasing but still unsatisfying. PATIENT SUMMARY: In this review article, we look at current research regarding surgical management of stress urinary incontinence following radical prostatectomy. Many studies focus on how to predict treatment failure and outcomes after artificial urinary sphincter implantation. In addition, more information on the long-term results after male sling implantation is now available.
Authors: Hanson Zhao; Colby P Souders; Paige K Kuhlmann; Kai Dallas; Karyn Eilber; Jennifer T Anger Journal: Int Neurourol J Date: 2021-05-05 Impact factor: 2.835
Authors: Antonio Tienza; Petra L Graham; Jose E Robles; Fernando Diez-Caballero; David Rosell; Juan I Pascual; Manish I Patel; Sean F Mungovan Journal: Int Neurourol J Date: 2020-06-30 Impact factor: 2.835
Authors: Alexander Kretschmer; Tanja Hüsch; Ralf Anding; Tobias Pottek; Achim Rose; Werner Struss; Fabian Queissert; Carsten M Naumann; Joanne N Nyarangi-Dix; Bernhard Brehmer; Axel Haferkamp; Ricarda M Bauer Journal: Int Braz J Urol Date: 2020 Jul-Aug Impact factor: 1.541
Authors: Emily M Yura; Christopher J Staniorski; Jason E Cohen; Liqi Chen; Ashima Singal; Francisco E Martins; Matthias D Hofer Journal: J Clin Med Date: 2021-12-13 Impact factor: 4.241